shares in evotec fell on friday after the company cut its fullyear guidance due to the impact of a cyberattack in the second quarter at 0956 gmt shares were down 45 to eur2272 after falling more than 5 earlier in the session for 2023 the company now sees revenue between 750 million euros and 790 million euros 8235 million8674 million down from a previous forecast range of eur820 millioneur840 million the german biotechnology company also lowered its forecast for adjusted earnings before interest taxes depreciation and amortization to a range of eur60 millioneur80 million compared with its prior estimate of eur115 millioneur130 million the company said performance in the first quarter shows that the underlying business dynamic is intact but a cyberattack in april hit productivity throughout the second quarter in response to the criminal cyberattack evotec took immediate action to contain and remediate the attack by taking its externalfacing systems offline it said this was necessary to protect partners and stakeholders and so evotec could ensure that integrity of scientific data wasnt affected it said evotec started operations again at the end of april with productivity reaching about 50 in may and more than 80 in june it said despite the lowered 2023 guidance the company maintains its action plan 2025 with expected revenue above eur1 billion and adjusted ebitda of more than eur300 million for the first half the company estimates revenue above eur370 million missed revenue could be partly recoverable during the next six months although market circumstances arent expected to improve the company said oneoff net costs related to managing the impact of the cyberattack amount to around eur25 million evotec said